Expert Warnings Over Unnecessary Menopause Tests Gaining Ground in Sweden

A growing concern has emerged regarding unnecessary menstrual tests and hormone treatments marketed towards women undergoing menopause in Sweden, with health experts cautioning against their efficacy. Gynecologist Angelica Lindén Hirschberg from the Karolinska Institute highlights that hormone levels during menopause fluctuate significantly, advising against self-testing and urging women to be wary of misleading products. Many hormonal tests, particularly those measuring FSH in urine, are promoted by pharmacy chains like Apotek Hjärtat, yet there is a consensus from the Swedish Society of Obstetrics and Gynecology that these tests lack scientific validation.

Research published in the British Medical Journal (BMJ) corroborates these claims, noting that the rapid proliferation of tests and supplements aimed at menopausal women lacks a solid scientific foundation. Both Canadian and British researchers have highlighted the unnecessary costs these products may impose on women, giving rise to concerns about consumer misorientation. These supplements, which promise relief from common menopausal symptoms like hot flashes and sleep disturbances, often do not possess adequate evidence of effectiveness, leaving many women potentially misled and financially burdened.

Experts assert that the commercialization of these unproven tests exploits women's fears surrounding menopause, urging greater consumer awareness. While pharmacies defend their offerings as potentially reliable based on personal judgment, the medical community stresses the importance of professional guidance and evidence-based approaches for managing menopausal symptoms.

Consequently, it remains crucial for women to critically evaluate such products and consult healthcare providers before undertaking any tests or treatments that lack scientific support.